Inflammatory response to aorto-bifemoral graft surgery

International Angiology

Volumn 16, Issue 1, 1997, Pages 55-64

  Parsson H N ^a   Nassberger L ^a   Norgren, L ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Aorto bifemoral surgery; Complement; Cytokines; Grafts

Indexed keywords

C REACTIVE PROTEIN; COMPLEMENT COMPONENT C5A; CYTOKINE; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERLEUKIN 8; PLASMA PROTEIN; POLITEF; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; AORTA GRAFT; ARTICLE; BLOOD SAMPLING; BYPASS SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; DACRON IMPLANT; FEMALE; HUMAN; INFLAMMATION; LERICHE SYNDROME; LEUKOCYTE; LYMPHOCYTE COUNT; MALE; PATIENT MONITORING; POSTOPERATIVE PERIOD; SURGICAL INJURY;

AGED; AORTA, ABDOMINAL; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; COMPLEMENT ACTIVATION; CYTOKINES; FEMALE; FEMORAL ARTERY; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; POLYETHYLENE TEREPHTHALATES; POLYTETRAFLUOROETHYLENE; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 0031009181     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Dinarello CA, Cannon JG, Wolff SM. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 1986; 163:1433-50.
2. Gauldie J, Richards C, Harnish D, Landsdorp P, Bauman H. Interferon b2/B-cell stimulatory factor type 2 shares identity with monocyte-derived and hepatocyte-stimulation factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 1987;84:7251-5.
3. Heinrich PC, Castell JV, Andus T. Interleukin-6 and the acute phase response. Biochem J 1990;265:621-36.
4. Kushner I. Mechanisms involved in the acute phase response and its biological and clinical significance. Clin Immunol 1991;11:129-32.
5. Oppenheim JJ, Kovacs EJ, Matsushima K, Durum SK. There is more than one interleukin 1. Immunol Today 1986;7:45-56.
6. Michie HR, Guillou PJ, Wilmore DW. Tumour necrosis factor and bacterial sepsis. Br J Surg 1989;76:670-1.
7. Millar AB, Singer M, Meager A, Foley NM, Johnson NMcI, Rook GAW. Tumour necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet 1989;2(8665):712-4.
8. Baggiolini M, Walz A, Kunkel S. Neutrophil-activating peptide-1/interleukin-8, a novel cytokine that activates neutrophils. J Clin Invest 1989;84:1045-9.
9. Degianis D. Soluble IL-2 receptors in patients with systemic sclerosis: clinical and laboratory correlations. Arthritis Rheum 1990;33:375.
10. Baigrie RJ, Lewis CE, Lamont PM, Morris PJ, McGee JOD. Effect of major surgery on the release of interferon gamma by peripheral blood mononuclear cells. Cytokine 1992;4:63-5.
11. Høgevold HE, Kierulf P, Øvstebø R, Reikerås O. Acute phase reactants and interleukin 6 after total hip replacement. Eur J Surg 1992; 158:339-45.
12. Ohzato H, Yoshizaki K, Nishimoto N et al. Interleukin-6 as a new indicator of inflammatory status: detection of serum levels of interleukin-6 and C-reactive protein after surgery. Surgery 1990;111:201-9.
13. Baigrie RJ, Lamont PM, Kwiatkowski R, Dellman J, Morris PJ. Systemic cytokine response after major surgery. Br J Surg 1992;79:757-60.
14. Damas P, Ledoux P, Nys M et al. Cytokine serum level during severe sepsis in human IL-6 as a marker of severity. Ann Surg 1992;215:356-62.
15. Faist E, Storck M, Hültner L et al. Functional analysis of monocyte activity through synthesis patterns of proinflammatory cytokines and neopterin in patients in surgical intensive care. Surgery 1992;112:562-72.
16. Espevik T, Nissen-Meyer J. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytoloxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 1986;95:99-105.
17. Waage A, Halstensen A, Shalaby R, Brandtzaeg P, Kierulf P, Espevik T. Local production of tumour necrosis factor α, interleukin 1, and interleukin 6 in meningococcal meningitis. J Exp med 1989;170:1859-67.
18. Krause TJ, Robertsson FM, Liesch JB, Wasserman AJ, Greco RS. Differential production of interleukin 1 on the surface of biomaterials. Arch Surg 1990;125:1158-60.
19. Margiotta MS, Robertsson FS, Greco RS. The adherence of endothelial cells to Dacron induces the expression of the intercellular adhesion molecule (ICAM-1). Ann Surg 1992;216:600-4.
20. Andersson J, Eklöf B, Neglén P, Thomas D. Metabolic changes in blood and skeletal muscle in reconstructive aortic surgery. Am Surg 1979;189:283-9.
21. Van Snick J. Interleukin 6: An overview. Ann Rev Immunol 1990;8:253-78.
22. Craddock PR, Fehr J, Brigham KL, Kronenberg RS, Jacob HS. Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis. N Engl J Med 1977;296:769-74.
23. Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Blackstone EH, Kirklin JW. Complement activation during cardiopulmonary bypass: evidence for generation of C3a and C5a anaphylatoxins. N Engl J Med 1981;304:497-503.
24. Ryhanen P, Herva E, Hollman A, Nuutinen L, Pihlajaniemi R, Saarela E. Changes in peripheral blood leucocyte counts, lymphocyte subpopulations and in vitro transformation after heart valve replacement. J Thorac Cardiovasc Surg 1979;77:259-65.
25. De Mol Van Otterloo JCA, Van Bockel JH, Ponfoort ED, Brommer EJP, Hermans J, Daha MR. The effects aortic reconstruction and collagen impregnation of Dacron prostheses on the complement system. J Vase Surg 1992;16:774-83.
26. Craddock PR, Hammerschmidt D, White JG, Dalmasso AP, Jacob HS. Complement (C5a)-induced granulocyte aggregation in vitro. J Clin Invest 1977;60:260-4.
27. Polley MJ, Nachman RL. Human platelet activation by C3a and C3a des-arg. J Zxp Med 1983;158:603-15.
28. Kirklin JK, Westaby S, Blackstone EH, Kirklin JW, Chenoweth DE, Pacifico AD. Complement and the damaging effects of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1983;86:845-57.
29. Brothers TE, Graham LM, Till GO. Systemic effects of prosthetic vascular graft implantation. Surgery 1988;104:375-82.
30. Kottke-Marchant K, Anderson JM, Miller KM, Marchant RE, Lazarus H. Vascular graft-associated complement activation and leucocyte adhesion in an artificial circulation. J Biomed Mat Res 1987;21:379-97.
31. Shepard AD, Gelfand JA, Callow AC, O'Donnel TF. Complement activation by synthetic vascular prostheses. J Vasc Surg 1984;1:829-38.
32. Parsson H, Jundzill W, Jonung T, Thörne J, Norgren L. The adhesion of labelled neutrophils on synthetic vascular grafts. Eur J Vasc Surg 1993;7:257-62.
33. Pankiwsky DA, Ziats NP, Topham NS, Ratnoff OD, Anderson JM. Morphologic characteristics of absorbed human plasma proteins on vascular grafts and biomaterials. J Vasc Surg 1990;11:599-606.
34. Kalman PG, McCullough DA, Ward ChA. Evacuation of microscopic air bubbles from Dacron reduces complement activation and platelet aggregation. J Vasc Surg 1990;11:591-8.
35. Quinones-Baldrich WJ, Moore WS, Ziomek S, Chvapil. Development of a leak-proof knitted Dacron vascular prosthesis. J Vase Surg 1986;3:895-903.
36. Norgren L, Holtås S, Persson G, Ribbe E, Saxne T, Thörne J. Immune response to collagen impregnated dacron double velour grafts for aortic and aortofemoral reconstructions. Eur J Vasc Surg 1990;4:379-84.
37. Pärsson H, Jönsson BA, Norgren L, Strand SE, Thörne J. Experimental evaluation of small diameter synthetic arterial grafts. Int Angiol 1988;7:60-4.
38. Faist E, Mewes A, Strasser T et al. Alteration of monocyte function following major injury. Arch Surg 1988;123:287-92.
39. Lahat N, Shtiller R, Zlotnik AY, Merin G. Early IL-2/sIL-2R surge following surgery leads to temporary immune refractoriness. Clin Exp Immunol 1993;92:482-6.
40. Tatter PI. Blood transfusion and infectious complications following colorectal cancer surgery. Br J Surg 1988;75:789-95.
41. Verwaal VJ, Wobbes TH, Koopman-van Gemert AWMM, Buskens FGM, Theeuwes AGM. Effect of perioperative blood transfusion and cell saver on the incidence of postoperative complications in patients with an aneurysm of the abdominal aorta. Eur J Surg 1992;158:477-80.
42. Nässberger L, Sturfelt G, Thysell H. Serum levels of the soluble interleukin-2 receptor are dependent on the kidney function. Am J Nephrol 1992;12:401-5.
43. Waage A, Halstensen A, Espevik T. Associatin between tumour necrosis factor inserum and fatal outcome in patients with meningococcal disease. Lancet 1987;1(8529):355-7.